Penn Mental Health AIDS Research Center

宾夕法尼亚州心理健康艾滋病研究中心

• 批准号: 10819857
• 负责人: Kelly L Jordan-Sciutto
• 金额: $ 24.38万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-15 至 2025-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10819857
• 关键词: AIDS prevention; Accident and Emergency department; Acquired Immunodeficiency Syndrome; Address; Affect; Area; Behavior; COVID-19 pandemic; Caring; Cities; Client; Clinical; Cluster Analysis; Cocaine; Communities; Comprehensive Health Care; Counseling; Coupled; Data; Detection; Development; Diagnosis; Environment; Epidemic; Equipment; Equity; Evaluation; Face; Feedback; Fentanyl; Fright; Funding; Geographic Locations; HIV; HIV diagnosis; Health; Health Personnel; Health Priorities; Health Service Area; Healthcare; Height; Heroin; Human immunodeficiency virus test; Incidence; Injecting drug user; Injections; Integrated Delivery of Health Care; Legal; Link; Mental Health; Methamphetamine; Methodology; Needles; Neighborhoods; Newly Diagnosed; Participant; Patient Education; Perception; Persons; Pharmaceutical Preparations; Philadelphia; Prevention; Provider; Public Health; Recording of previous events; Research; Risk; Service delivery model; Service provision; Services; Site; Social Work; Space-Time Clustering; Surveys; System; Training; Trauma; United States National Institutes of Health; Unsafe Sex; community organizations; community partnership; coronavirus disease; cost; experience; health care service; infection rate; injection drug use; innovation; interest; meetings; operation; outpatient programs; outreach; preference; prescription opioid; prevention service; response; scale up; service organization; service providers; social stigma; substance use treatment; success; testing services; transmission process; treatment center; willingness

Project Summary/Abstract People incidence who inject drugs (PWID) are disproportionately affected by HIV incidence in Philadelphia. The HIV in Philadelphia is growing and returning to pre-COVID pandemic levels.At present, the city health department's Department of HIV Health funds many community and clinical health providers for HIV testing and counseling services, including HIV Service Organizations (HSOs), substance use treatment centers, and emergency departments, which have facilitated the detection of many new cases among PWID in Philadelphia. Despite these successes, increasing infection rates in PWID suggest a need for scaled-up detection and linkage strategies. Reliance on traditional HIV prevention providers may yield missed opportunities for HIV diagnoses, timely linkage-to-care, and cluster detection and response. Leveraging providers in healthcare and social service environments outside of traditional HIV prevention settings in neighborhoods with high rates of IDU may maximize opportunities for expanding efforts for HIV cluster detection and response. The extent to which nonclinical HSO-alternative service providers in these areas understand IDU as a significant contributor to the HIV epidemic, routinely conduct or refer PWID high-quality HIV testing services, and are willing and capable to integrate or scale-up HIV testing services within current clinical operations at their agency is poorly understood. To address these gaps, we propose a 2-year study to conduct the following aims: (Aim 1) Employ persons with lived experiences/histories of IDU to conduct secret shopper methodologies toward understanding the current HIV testing/referral practices in nonclinical HSO-alternative outpatient service facilities (N = 15) in Philadelphia neighborhoods with high IDU; (Aim 2) Deploy surveys with N = 100 PWID living without HIV to evaluate environmental preferences for HIV prevention services in nonclinical HSO-alternative outpatient service facilities in Philadelphia; and (Aim 3) Engage with representatives from secret shopper-evaluated facilities through stakeholder meetings to discuss secret shopper feedback, their perceptions of the HIV epidemic among PWID in their service area, and their capacity for HIV prevention services. The proposed study will facilitate local priorities pertaining to the Diagnose pillar of the Ending the HIV Epidemic Initiative and support the city health department's HIV cluster detection and response strategies. Leveraging HSO-alternative providers' capacities to conduct, refer, and coordinate HIV testing will maximize equitable access to HIV prevention for PWID and opportunities to identify new HIV cases and unidentified clusters missed via traditional HIV testing environments, like HSOs.

项目摘要/摘要 人们 发病率 谁注射药物（PWID）受到费城HIV发病率的不成比例。艾滋病毒 在费城正在增长，并恢复到前杂散的大流行级别。 部门艾滋病毒卫生部为艾滋病毒测试和 咨询服务，包括艾滋病毒服务组织（HSO），药物使用治疗中心以及 急诊部门促进了费城PWID中许多新病例的发现。 尽管取得了这些成功，但PWID的感染率提高表明需要扩展检测和连锁 策略。对传统艾滋病毒预防提供者的依赖可能会产生失踪的艾滋病毒诊断机会， 及时的链接到服务，集群检测和响应。利用医疗保健和社会服务提供商 在IDU率高的社区中，传统的HIV预防环境以外的环境可能 最大化扩大HIV群集检测和反应努力的机会。在多大程度上 这些领域的非临床HSO替代服务提供商将IDU理解为重要的贡献者 艾滋病毒流行，常规进行或参考PWID高质量的艾滋病毒测试服务，并愿意并且有能力 在当前机构的当前临床操作中整合或扩大艾滋病毒测试服务的理解很少。 为了解决这些差距，我们提出了一项为期两年的研究，以进行以下目的：（目标1） IDU的生活经验/历史，以进行秘密购物者方法来理解当前 费城非临床HSO-Alterthative门诊服务设施（n = 15）的HIV测试/推荐实践 高idu的社区； （AIM 2）部署n = 100个没有艾滋病毒的n = 100 pwid的调查以评估 非临床HSO替代门诊服务设施中艾滋病毒预防服务的环境偏好 在费城； （AIM 3）与秘密购物者评估设施的代表通过 利益相关者会议讨论秘密购物者的反馈，他们对PWID的艾滋病毒流行的看法 在他们的服务领域以及他们的艾滋病毒预防服务能力。拟议的研究将促进本地 与结束艾滋病毒流行倡议的诊断支柱有关的优先事项和支持城市健康 部门的HIV群集检测和反应策略。利用HSO替代提供商的能力 进行，参考和协调艾滋病毒测试将使PWID和 通过传统的艾滋病毒测试环境中错过的新艾滋病毒病例和未知群集的机会， 像HSO。